Vanda Pharmaceuticals, Inc. (VNDA)
6.50
+0.28
(+4.50%)
USD |
NASDAQ |
May 27, 15:01
Vanda Pharmaceuticals Cash from Investing (Quarterly) : 20.23M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AnaptysBio, Inc. | 34.98M |
| Amgen, Inc. | -716.00M |
| Gossamer Bio, Inc. | 41.61M |
| BridgeBio Pharma, Inc. | -42.74M |
| Geron Corp. | 51.86M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.22M |
| Cash from Financing (Quarterly) | -0.776M |
| Free Cash Flow | -127.30M |
| Free Cash Flow Per Share (Quarterly) | -0.8483 |
| Free Cash Flow to Equity (Quarterly) | -50.89M |
| Free Cash Flow to Firm (Quarterly) | -50.44M |
| Free Cash Flow Yield | -33.10% |